Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CASPER Study: Copeptin in Adolescent Participants With Type 1 Diabetes and Early Renal Hemodynamic Function

NCT03618420 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT03618420
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03618420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CASPER Study: Copeptin in Adolescent Participants With Type 1 Diabetes and Early Renal Hemodynamic Function
Lead sponsor
University of Colorado, Denver
Phase
Phase 1/2
Overall status
Completed
Start date
October 1, 2018
Completion date
August 1, 2021
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune diabetes, diabetes mellitus complication, diabetes mellitus, type 1, diabetic nephropathies, juvenile diabetes, nephropathy, type 1 diabetes mellitus